X
More than 60,000 patients use Brite
4.6 stars
Your health finally understandable with Brite
Enter email and you're done. No subscription, no credit card.
Search, tap and you're done. Over 3,400 medicines.
Check, remind, get an overview.
Sarah K., 34
I finally understand my therapy. The app reminds me, answers my questions — and I don't feel alone with it anymore.
Mirabegron is the first beta-3 agonist for overactive bladder and works quite differently from the classic anticholinergics: it relaxes the bladder during the filling phase instead of blocking muscle contraction. That is why it causes no dry mouth and no cognitive side effects — an important advantage in older age. In return, it calls for a different kind of attention: blood pressure can rise and should be measured before starting and during treatment.
See more detail.gif)
Apart from the circulation, the profile is comparatively unremarkable — which does not mean it is empty.
Mirabegron is not suitable in severe, uncontrolled high blood pressure, in severe liver impairment or in end-stage kidney failure. It is not recommended during pregnancy and breastfeeding; the data are limited, and guidance comes from the assessments of Embryotox (the German pharmacovigilance centre for embryonic toxicology) and from the guide medications during pregnancy.⁴ Side effects you notice should be documented and reported — how to do that is explained under side effects of medications.
In practice this point matters more than its brevity in the package leaflet suggests — and it mainly affects men.
If the bladder outlet is narrowed, for instance by an enlarged prostate, the bladder has to work against resistance. A medicine that relaxes the bladder muscle can, in this situation, mean that emptying is no longer complete: residual urine increases, in the worst case up to acute urinary retention.
Mirabegron does not block the emptying contraction — in that respect the starting position is more favourable than with an anticholinergic. Caution is still needed with existing bladder outlet obstruction, especially in combination with an anticholinergic.
Mirabegron's typical interaction is different from that of the anticholinergics. Mirabegron inhibits the enzyme CYP2D6. Medicines that are broken down by this enzyme can therefore build up in the blood — with a correspondingly stronger effect and more side effects.
| Combination | Consequence | What to do |
|---|---|---|
| Beta blockers such as metoprolol | Level can rise: more tiredness, slower pulse, a stronger drop in blood pressure | Monitor pulse and blood pressure closely, have a dose adjustment checked by a doctor |
| Certain antidepressants broken down via CYP2D6, e.g. tricyclic substances | Stronger effects and side effects | Have the combination assessed specifically |
| Digoxin | Level can rise | Usually start low and check levels |
| Certain antiarrhythmics | Raised levels possible | Coordinate with a specialist |
| Strong CYP3A4 inhibitors | Mirabegron level can rise | Consider the lower dose step |
| Anticholinergics for the bladder | Residual urine can increase | Combine only deliberately, check residual urine (section 9) |
The most important everyday case is the first: a great many people with an overactive bladder also take a beta blocker. This combination is not forbidden, but it deserves attention — not least because mirabegron tends to raise blood pressure while the beta blocker lowers it. Check every new prescription against your existing list, for instance with the interaction check, and keep an up-to-date medication plan to hand.
Because mirabegron and the anticholinergics act at different points, the idea of combining the two is an obvious one. And in certain situations that is exactly what is done: when a single substance at an adequate dose has not achieved enough over several weeks, but the symptoms are still very burdensome.
However, this is a decision for specialist care and not a standard step. Two points go with it:
Before combining, it is therefore almost always worth asking an honest interim question: was the single substance tried for long enough and at an adequate dose — and was bladder training really part of it? In many cases there is more potential there than in a second tablet.
A point that concerns many people and is rarely answered objectively. Mirabegron is considerably more expensive than the anticholinergics available as generics, such as oxybutynin or solifenacin, whose patent protection expired years ago.
It is nevertheless prescribed and reimbursed by statutory health insurance — it is a fully licensed medicine that can be prescribed in the normal way. But because practices are bound by rules on cost-effective prescribing, a cheaper alternative is usually tried first. A clear reason for mirabegron — such as intolerance of anticholinergics, advanced age, cognitive impairment or angle-closure glaucoma — is therefore helpful and belongs in your records.
Here too, what applies to the whole group of substances applies — and it is said clearly too rarely: the number of urgency episodes, trips to the toilet and incontinence episodes falls, but becoming completely free of symptoms is the exception. The benefit is real and noticeable in everyday life, but it is gradual.²,³
What sets mirabegron apart from the anticholinergics is therefore not a stronger effect but the chance that the treatment is kept up at all. A great many treatments with anticholinergics end after a few months — not because they do not work, but because dry mouth and constipation disrupt everyday life more than the bladder does. In the end, a drug you can tolerate is the more effective one.
Urinary incontinence is a common and treatable complaint.⁵ Left untreated, it often leads to withdrawal, less physical activity and a higher risk of falls on the way to the toilet at night — reasons enough to raise the subject objectively.
Yes, on this point it really is different. Mirabegron works via beta-3 receptors and does not interfere with the cholinergic system, which is responsible for saliva flow, bowel movement and near vision. Dry mouth to the typical anticholinergic extent is therefore not part of its profile. That does not mean mirabegron is free of side effects — blood pressure can rise, and headaches and urinary tract infections do occur. You swap one risk for another; what matters is which one is easier to manage in your situation.
High blood pressure in itself does not rule out mirabegron — but severe, uncontrolled high blood pressure that is hard to manage does. The difference is important: if your blood pressure is well controlled and you measure it regularly, you can usually be given mirabegron, but you will need closer checks at the start. If your readings fluctuate a lot or are persistently high, your blood pressure should be stabilised first. Take a series of readings over one to two weeks to your appointment — that says more than a single measurement at the practice.
Not yet. Mirabegron needs time: first effects usually show after one to two weeks, and a fair assessment is made after about eight to twelve weeks. Before that, three questions are worth asking: has the dose actually been adjusted yet? Is bladder training running alongside? And what does the comparison in your bladder diary look like — not the feeling, but the numbers? If nothing has happened even after that, switching or combining is a matter for the consulting room, not quietly stopping.
Keep a series of readings and show it at your appointment — instead of reporting from memory.
